In-lisenceLinkedbio Partnering Service packLingmed analyst team will support you on in-licensing assets. We support your asset screening - the search will be tailed based on your search criteria to provide China market monitoring, including asset screening, recommendation and initial evaluation to support your BD efforts in China market. Lingmed team will arrange partnering meetings to facilitate the direct dialogues, suggest deal structure to support your deal closingLingmed innovative assets recommendation webinar >> |
|